AbbVie: Q1 Earnings Insights - AbbVie (NYSE:ABBV)

AbbVie ABBV reported its Q1 earnings results on Friday, April 29, 2022 at 07:44 AM.

Here's what investors need to know about the announcement.

AbbVie beat estimated earnings by 0.64%, reporting an EPS of $3.16 versus an estimate of $3.14.

Revenue was up $528.00 million from the same period last year.

Last quarter the company beat on EPS by $0.03 which was followed by a 1.52% increase in the share price the next day.

Here's a look at AbbVie's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	3.28	3.22	3.09	2.83
EPS Actual	3.31	3.33	3.11	2.95
Revenue Estimate	14.98B	14.32B	13.63B	12.76B
Revenue Actual	14.89B	14.34B	13.96B	13.01B

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

AbbVie management provided guidance for FY 2022, expecting earnings between $13.92 and $14.12 per share.

To track all earnings releases for AbbVie visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.